Non-hormonal treatment of vasomotor symptoms in gynecological cancer patients

L. Del Pup, T. Maggino

Research output: Contribution to journalArticle

Abstract

Gynaecological cancer patients generally suffer from an earlier and more severe menopausal syndrome than the general female population. Hormone replacement therapy is often contraindicated and there are non-hormonal treatments that are proven to be more effective than placebo in randomized controlled trials, e.g., some antidepressants, gabapentine and clonidine. The main limits to the use of these drugs in controlling hot flashes are the off-label use for this purpose, the very short follow-up and the fact that data come from studies performed on breast cancer, not on gynecological cancer patients. Patients believe that drugs derived from plants could be effective in relieving hot flashes and that they are harmless. Evidence is contrary to this belief and estrogen-sensitive cancer patients should be warned of the potential, though very weak, estrogenic effect of phytoestrogens and other "natural" drugs, and that their efficacy is close to that of a placebo.

Original languageEnglish
Pages (from-to)299-303
Number of pages5
JournalEuropean Journal of Gynaecological Oncology
Volume31
Issue number3
Publication statusPublished - 2010

Fingerprint

Hot Flashes
Neoplasms
Estrogens
Placebos
Pharmaceutical Preparations
Off-Label Use
Phytoestrogens
Hormone Replacement Therapy
Clonidine
Therapeutics
Antidepressive Agents
Randomized Controlled Trials
Breast Neoplasms
Population

Keywords

  • Antidepressants
  • Clonidine
  • Gabapentin
  • Gynecological cancers
  • Menopausal syndrome
  • Phytoestrogens

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Non-hormonal treatment of vasomotor symptoms in gynecological cancer patients. / Del Pup, L.; Maggino, T.

In: European Journal of Gynaecological Oncology, Vol. 31, No. 3, 2010, p. 299-303.

Research output: Contribution to journalArticle

@article{56d2113ba3f441b89e2d680d47a956a0,
title = "Non-hormonal treatment of vasomotor symptoms in gynecological cancer patients",
abstract = "Gynaecological cancer patients generally suffer from an earlier and more severe menopausal syndrome than the general female population. Hormone replacement therapy is often contraindicated and there are non-hormonal treatments that are proven to be more effective than placebo in randomized controlled trials, e.g., some antidepressants, gabapentine and clonidine. The main limits to the use of these drugs in controlling hot flashes are the off-label use for this purpose, the very short follow-up and the fact that data come from studies performed on breast cancer, not on gynecological cancer patients. Patients believe that drugs derived from plants could be effective in relieving hot flashes and that they are harmless. Evidence is contrary to this belief and estrogen-sensitive cancer patients should be warned of the potential, though very weak, estrogenic effect of phytoestrogens and other {"}natural{"} drugs, and that their efficacy is close to that of a placebo.",
keywords = "Antidepressants, Clonidine, Gabapentin, Gynecological cancers, Menopausal syndrome, Phytoestrogens",
author = "{Del Pup}, L. and T. Maggino",
year = "2010",
language = "English",
volume = "31",
pages = "299--303",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "3",

}

TY - JOUR

T1 - Non-hormonal treatment of vasomotor symptoms in gynecological cancer patients

AU - Del Pup, L.

AU - Maggino, T.

PY - 2010

Y1 - 2010

N2 - Gynaecological cancer patients generally suffer from an earlier and more severe menopausal syndrome than the general female population. Hormone replacement therapy is often contraindicated and there are non-hormonal treatments that are proven to be more effective than placebo in randomized controlled trials, e.g., some antidepressants, gabapentine and clonidine. The main limits to the use of these drugs in controlling hot flashes are the off-label use for this purpose, the very short follow-up and the fact that data come from studies performed on breast cancer, not on gynecological cancer patients. Patients believe that drugs derived from plants could be effective in relieving hot flashes and that they are harmless. Evidence is contrary to this belief and estrogen-sensitive cancer patients should be warned of the potential, though very weak, estrogenic effect of phytoestrogens and other "natural" drugs, and that their efficacy is close to that of a placebo.

AB - Gynaecological cancer patients generally suffer from an earlier and more severe menopausal syndrome than the general female population. Hormone replacement therapy is often contraindicated and there are non-hormonal treatments that are proven to be more effective than placebo in randomized controlled trials, e.g., some antidepressants, gabapentine and clonidine. The main limits to the use of these drugs in controlling hot flashes are the off-label use for this purpose, the very short follow-up and the fact that data come from studies performed on breast cancer, not on gynecological cancer patients. Patients believe that drugs derived from plants could be effective in relieving hot flashes and that they are harmless. Evidence is contrary to this belief and estrogen-sensitive cancer patients should be warned of the potential, though very weak, estrogenic effect of phytoestrogens and other "natural" drugs, and that their efficacy is close to that of a placebo.

KW - Antidepressants

KW - Clonidine

KW - Gabapentin

KW - Gynecological cancers

KW - Menopausal syndrome

KW - Phytoestrogens

UR - http://www.scopus.com/inward/record.url?scp=77954101964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954101964&partnerID=8YFLogxK

M3 - Article

C2 - 21077473

AN - SCOPUS:77954101964

VL - 31

SP - 299

EP - 303

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 3

ER -